| Document |
Document Title |
|
WO/2024/008205A1 |
The present invention belongs to the technical fields of genetic engineering and enzyme engineering, and specifically relates to the use of MmBBK2 in the preparation of trypsin and chymotrypsin inhibitors. The MmBBK2 has an amino acid se...
|
|
WO/2024/008204A1 |
Provided is the use of MmPI in the preparation of a trypsin inhibitor. The amino acid sequence of the MmPI is as shown in SEQ ID NO. 1. In the present invention, it is confirmed that MmPI in mulberry leaves has a trypsin inhibitory activ...
|
|
WO/2024/011222A1 |
The subject invention provides compositions and methods for treating and/or preventing iron deficiencies and iron chlorosis in plants. Compositions comprising an iron-capturing ingredient are contacted with plant and/or its surrounding e...
|
|
WO/2024/008344A1 |
The invention relates to the use of an E. coli bacterial strain, for detecting in a liquid up to 50 mM, in condition of anaerobiosis, the presence, the absence or the amount of chlorate ions of formula ClO3 -, wherein said E. coli bacter...
|
|
WO/2024/007053A1 |
The present invention relates to bacterial strains and compositions, and their use for controlling diseases in plants and for promoting plant growth. In one aspect, the isolated bacterial strain RR15 of the genus Pantoea, deposited under...
|
|
WO/2024/011248A1 |
Compositions and articles comprising scleroglucan that can be used for culturing and enumerating microorganisms even after exposure to sterilizing doses of radiation. The compositions also include one or more water swellable polymers oth...
|
|
WO/2024/008845A1 |
The present invention relates to novel exocellular polysaccharides resulting in improved texture of dairy products and LAB strains producing such polysaccharides. The present invention also relates to methods of using the polysaccharides...
|
|
WO/2024/002149A1 |
Provided are a recombinant type-III collagen and a method for preparing same and use thereof. The amino acid sequences of the recombinant type-III collagen are set forth in SEQ ID NOs: 1, 2, and 3.
|
|
WO/2024/002335A1 |
Provided is a live bacteria strain of a species from Pseudomonas sp. such as Pseudomonas aeruginosa and uses thereof. More particularly, provided is a live bacteria strain of P.aeruginosa with reduced OprF activity, to a vaccine against ...
|
|
WO/2024/004371A1 |
Provided is a live bacteria quantifying method comprising: a deposition step in which bacteria is placed in a measuring vessel containing a redox substance that is permeable to the cell membranes of the live bacteria to be measured, that...
|
|
WO/2024/004983A1 |
Erythritol utilization-deficient mutant Trichoderma spp. and production of target substance using said mutant Trichoderma spp. Mutant Trichoderma spp. the ability of which to utilize erythritol has been decreased or eliminated, wherein t...
|
|
WO/2024/002131A1 |
The present invention relates to the technical field of bioengineering, and particularly, to an engineered microorganism for efficiently expressing D-psicose 3-epimerase. The engineered microorganism comprises a constructed recombinant e...
|
|
WO/2024/000364A1 |
The present invention relates to the technical field of gene engineering and mutagenesis, and provides a corynebacterium glutamicum (C. glutamicum) efficient mutant, a recombinant bacterium construction method and a use. A highly conserv...
|
|
WO/2024/003160A1 |
The patent is related to use of one or more Pichia kluyveri strains for inhibiting or delaying growth of Saccharomyces spp. in beverages, preferably beverage with reduced alcohol content. Provided herein are also Pichia kluyveri deposite...
|
|
WO/2024/001260A1 |
Provided in the present application is a method for preparing a degradable fabric, which relates to the technical field of garment fabrics. A method for preparing a degradable fabric, which comprises the following steps: brewing tea with...
|
|
WO/2024/003950A1 |
The present invention refers to a Y-type bioreactor for microbial gas fermentation comprising an aeration chamber (2) provided with means (3) for mixing a culture broth contained within, at least a first (4) and a second gas feeding cham...
|
|
WO/2024/000620A1 |
Provided are a fusion protein and an immobilized enzyme comprising the fusion protein. The fusion protein comprises an epoxide hydrolase enzyme active moiety and a chitin protein binding moiety. By means of utilizing the specific affinit...
|
|
WO/2024/003323A1 |
The present invention relates to a method for the production of a fungal fermentation medium from brewer's spent grain (BSG) and to a fermentation medium obtainable accordingly, to a method for production of a fungal biomass by submerged...
|
|
WO/2024/005573A1 |
The present invention relates to a Bifidobacterium breve JKL2022 strain capable of mass-producing natural conjugated linoleic acid (CLA), and a method for mass-producing conjugated linoleic acid using the same. The method of the present ...
|
|
WO/2024/000368A1 |
The present invention relates to the technical field of genetic engineering, and provides recombinant Escherichia coli and a construction method therefor, and a method for synthesizing 1,5-pentanediamine. The recombinant Escherichia coli...
|
|
WO/2024/005033A1 |
Provided is a method for efficiently producing an aromatic compound by using a transformed coryneform bacterium. A method for producing an aromatic compound or a salt thereof, said method including a step for culturing a modified coryn...
|
|
WO/2024/004661A1 |
A mutant nitrile hydratase mutated from a nitrile hydratase, said nitrile hydratase being derived from Pseudonocardia thermophila and having an α subunit having 90% or more sequence identity with SEQ ID NO: 1 and a β subunit having 90%...
|
|
WO/2024/001184A1 |
A mutant of phytase APPAmut4 is provided. Compared with parents, the mutant has enhanced phytase thermostability, and an optimal mutant APPAmut9 can still retain about 70% of activity after being treated at 100 ℃ for 5 min. The provide...
|
|
WO/2024/005155A1 |
A production method of one embodiment, said production method being for producing a 4-(aminomethyl)cyclohexane-1-carboxylic acid from 1,4-bis(aminomethyl)cyclohexane, comprises using a protein that comprises an amino acid sequence having...
|
|
WO/2024/005443A1 |
The present invention relates to a novel Micrococcus flavus strain, a lysate thereof, a culture thereof, an extract from the culture, and uses thereof for improving skin condition. The strain has a skin condition-improving effect, and th...
|
|
WO/2024/003317A1 |
The present invention provides a method for increasing the ratio of epilactose:lactose and/or epilactose:lactulose in a mixture containing epilactose with other disaccharides by using a microorganism which preferentially consumes lactose...
|
|
WO/2024/006548A1 |
The present disclosure provides technologies relating to cell and/or viral particle lysis and/or nucleic acid preparation.
|
|
WO/2024/003035A1 |
The present invention relates to attenuated Piscirickettsia salmonis strains and their use as a vaccine.
|
|
WO/2024/004647A1 |
The purpose of the present invention is to provide heterotrophic microalgae having a high content of γ-aminobutyric acid, and a method for increasing the content of γ-aminobutyric acid in the heterotrophic microalgae. The present inv...
|
|
WO/2024/002331A1 |
A live bacteria strain with reduced capsules is provided. More particularly, a live bacteria strain (for example, a live Staphylococcus aureus strain) in which the production of capsules is reduced, to a vaccine against bacterial infecti...
|
|
WO/2024/003799A1 |
The present invention relates to a method for increasing the production of a nucleic acid comprising the step of limiting the total sulfur amount in the culture medium. The present invention further relates to the use of a culture medium...
|
|
WO/2024/005625A1 |
The present invention relates to a novel fermentation process using a particular strain of Kluyveromyces marxianus, referred to as KMPROTEO 1, to obtain a single-cell protein useful in the food industry. In the present description, the i...
|
|
WO/2024/006060A1 |
Solid, porous, glass-based substrate for storage and delivery of useful microorganisms are described. Materials include one or more microorganisms lyophilized on the substrate, e.g., in the form of a lyophilized biofilm. The materials ca...
|
|
WO/2024/004921A1 |
The present invention addresses the problem of providing a modified oxygenase capable of epoxidating specifically only the position-ω3 in a highly unsaturated fatty acid. The present invention relates to: a polypeptide comprising an ami...
|
|
WO/2024/005867A1 |
Fluid analyzation devices, methods, and systems are disclosed including an analyzation device comprising a sample vessel having an outer surface, a microchannel within the confines of the outer surface, a first port extending through the...
|
|
WO/2024/001593A1 |
Provided is an engineered ketoreductase polypeptide capable of preparing chiral alcohols, especially for catalyzing the reduction of ethyl 4-chloroacetoacetate to produce ethyl (R) -4-chloro-3-hydroxybutyrate. The polypeptides has high c...
|
|
WO/2024/001838A1 |
Provided are a symbiotic bacterium in humans for promoting hair growth and use thereof. Specifically, provided is use of Staphylococcus hominis in treating alopecia or promoting hair growth, skin repair and regeneration and the like. Als...
|
|
WO/2024/004139A1 |
Provided is fermented milk that contains Lacticaseibacillus paracasei bacteria and milk fat, wherein the milk fat constitutes at most 2.0 mass% of the total mass of the fermented milk.
|
|
WO/2024/001460A1 |
The present application discloses a method and carrier for biosynthesis of astaxanthin. The method comprises: realizing biosynthesis of astaxanthin in engineering bacteria capable of expressing β-carotene ketonase and β-carotene hydrox...
|
|
WO/2024/001242A1 |
A polypeptide and a use thereof are provided. The polypeptide comprises an N-terminal sequence and a C-terminal sequence, the N-terminal sequence comprising one or more repeating units, and said repeating unit comprising an amino acid se...
|
|
WO/2024/000237A1 |
Disclosed in the present invention is the use of IAA-PO1 gene in inducing primordium formation of Pleurotus ostreatus and resisting stress during the growth and development of Pleurotus ostreatus, which use belongs to the technical field...
|
|
WO/2024/005204A1 |
Provided is a novel protein, or the like, as a trispecific tribody in which antitumor effects have been augmented. The present invention relates to a fusion protein comprising a first chain and a second chain which are different from one...
|
|
WO/2023/247483A1 |
The present invention relates to a mixture of human milk oligosaccharides ("HMOs") comprising five fucosylated HMOs, as well as to an enzymatic process for making said mixture, wherein said synthesis comprises an α1-3/4-transfucosidase ...
|
|
WO/2023/249498A1 |
Disclosed are methods of epigenetic modification of microbes, including yeast and yeast starter cultures for use in fermentation of food products. The methods comprise contacting the microbe, yeast or yeast starter culture with an epigen...
|
|
WO/2023/245259A1 |
The present invention relates to plant growth promoting endophytes, preferably of plants of the Glycine genus, particularly plant growth promoting Curtobacterium sp. endophytes. The present invention also relates to seeds, plants, and pa...
|
|
WO/2023/247603A1 |
The invention generally proposes a method (1) for producing an object (2) from a vegetable material (3), comprising the following method steps: providing (4) genetically modified microorganisms (5), wherein the genetic modification (12) ...
|
|
WO/2023/248144A1 |
This invention relates to use of a strain of probiotic bacteria or derivatives thereof for increasing feed efficiency, enhancing growth and/or productivity, improving body weight or body composition, and/or increasing milk production in ...
|
|
WO/2023/247493A1 |
The use of a probiotic, particularly the Enterococcus faecium strain NCIMB 10415 which is named SF68® as probiotic active ingredient, in combination with butyric acid or a salt thereof to increase the enterocyte's health and consequentl...
|
|
WO/2023/249104A1 |
The present invention addresses the problem of providing a system for, when producing a single type of cellular product using at least two types of tissue derived from the same patient, ultimately providing said single type of cellular p...
|
|
WO/2023/247544A1 |
The present invention relates to microbial starter cultures. More specifically, a method for preparing a microbial culture such as a lactic acid bacteria (LAB) starter culture wherein at least one microbial strain such as a lactic acid b...
|
